March 3, 2025 Experience Haleon $3 billion secondary placing of ordinary shares The private placement included 700,000,000 ordinary shares
February 24, 2025 Experience InflaRx $30 million offering of ordinary shares and pre-funded warrants The ordinary shares are listed on the Nasdaq Global Market
February 24, 2025 Experience Oculis Holding $100 million follow-on equity offering The shares are listed on the Nasdaq Global Market and the Nasdaq Iceland Main Market
February 24, 2025 Experience Boston Gas $500 million senior notes offering The investment-grade notes are due 2035
February 18, 2025 Experience Primo Brands $1.4 billion exchange offers and $3.85 billion financings The transactions included new notes, the refinancing of a $3.1 billion term loan facility and a new $750 million revolving facility
February 18, 2025 Experience BioVersys CHF 80 million IPO and concurrent private placement We advised AMR Action Fund on its investment in BioVersys
February 11, 2025 Experience IBM $4.75 billion and €3.5 billion notes offering The investment-grade debt consists of nine tranches of notes
February 11, 2025 Experience Bank of America €3 billion senior notes offering The investment-grade debt offering consists of two tranches
February 10, 2025 Experience Oesterreichische Kontrollbank $1.25 billion notes offering The 4.5% notes are due 2030
February 7, 2025 Experience GH Research $150 million follow-on offering We advised GH Research on the offering of shares